GB731933A - Liquid preparations of therapeutically active substances for sub-cutaneous or intramuscular injection - Google Patents
Liquid preparations of therapeutically active substances for sub-cutaneous or intramuscular injectionInfo
- Publication number
- GB731933A GB731933A GB10348/52A GB1034852A GB731933A GB 731933 A GB731933 A GB 731933A GB 10348/52 A GB10348/52 A GB 10348/52A GB 1034852 A GB1034852 A GB 1034852A GB 731933 A GB731933 A GB 731933A
- Authority
- GB
- United Kingdom
- Prior art keywords
- active substances
- cutaneous
- sub
- polyoxyethylene glycol
- polyoxyethylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
A clear injectible liquid comprises a solution of a physiologically active substance in a mixture of water with at least one of the substances (a) polyoxyethylene glycol, (b) a polyoxyethylene glycol derivative of a partial ester of a polyhydric alcohol with a long chain fatty acid, (c) propylene glycol, the proportions of the ingredients in said solvent being such that the solution is stable, but precipitates the active substances on injection. Glycerol may be used in conjunction with propylene glycol. The active substances may be hormones, p anesthetics, antibiotics and histamin-antagonizing agents, many examples of all of which are given. Polyoxyethylene glycols of mol. weight of from 200-4000 may be employed. Polyoxyethylene glycol derivatives of the following esters are mentioned: sorbitan monolaurate, monopalmitate, monostearate, monooleate, trioleate, sorbitol hexastearate and the corresponding mannitan derivatives. Specifications 667,010 and 674,784 are referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US731933XA | 1951-04-28 | 1951-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB731933A true GB731933A (en) | 1955-06-15 |
Family
ID=22112293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB10348/52A Expired GB731933A (en) | 1951-04-28 | 1952-04-24 | Liquid preparations of therapeutically active substances for sub-cutaneous or intramuscular injection |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB731933A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0145493A2 (en) | 1983-12-14 | 1985-06-19 | The Upjohn Company | 11-Difluoromethyl and 11-fluoromethylene steroids |
EP0197308A2 (en) * | 1985-03-11 | 1986-10-15 | Morton Shulman | Composition and method for producing prolonged pain relief |
EP1446103A2 (en) * | 2001-10-19 | 2004-08-18 | Idexx Laboratories, Inc. | Injectable compositions for the controlled delivery of pharmacologically active compound |
EP1617847A2 (en) * | 2003-04-18 | 2006-01-25 | Idexx Laboratories, Inc. | Methods for the controlled delivery of pharmacologically active compounds |
-
1952
- 1952-04-24 GB GB10348/52A patent/GB731933A/en not_active Expired
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0145493A2 (en) | 1983-12-14 | 1985-06-19 | The Upjohn Company | 11-Difluoromethyl and 11-fluoromethylene steroids |
EP0197308A2 (en) * | 1985-03-11 | 1986-10-15 | Morton Shulman | Composition and method for producing prolonged pain relief |
EP0197308A3 (en) * | 1985-03-11 | 1987-08-26 | Morton Shulman | Composition and method for producing prolonged pain relief |
JPH064534B2 (en) | 1985-03-11 | 1994-01-19 | モートン シュルマン | Combination drug for long-term pain relief |
EP1446103A2 (en) * | 2001-10-19 | 2004-08-18 | Idexx Laboratories, Inc. | Injectable compositions for the controlled delivery of pharmacologically active compound |
EP1446103A4 (en) * | 2001-10-19 | 2011-01-12 | Idexx Lab Inc | Injectable compositions for the controlled delivery of pharmacologically active compound |
EP1617847A2 (en) * | 2003-04-18 | 2006-01-25 | Idexx Laboratories, Inc. | Methods for the controlled delivery of pharmacologically active compounds |
EP1617847A4 (en) * | 2003-04-18 | 2011-08-10 | Idexx Lab Inc | Methods for the controlled delivery of pharmacologically active compounds |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3849569A (en) | Composition containing procaine penicillin | |
GB1066459A (en) | Diagnostic aid | |
GB731933A (en) | Liquid preparations of therapeutically active substances for sub-cutaneous or intramuscular injection | |
ES291443A1 (en) | A procedure for preparing vitamin compositions (Machine-translation by Google Translate, not legally binding) | |
NL113277C (en) | PROCESS FOR THE PREPARATION OF ORGANIC CARBONIC ACID ESTERS FROM SALTS OF CARBONIC ACIDS AND ALKYL HALOGENIDES | |
US2457188A (en) | Benzocaine solution | |
GB2000025A (en) | Nitroimidazole formulations | |
BE603518A (en) | Derivatives of 4-halo-3-sulfamoylbenzoic acids and processes for their preparation | |
US4600582A (en) | Therapeutic treatment | |
Hellbaum et al. | Action of estrogen on release of hypophyseal luteinizing hormone | |
ES353413A1 (en) | Quinoline Derivatives | |
GB490942A (en) | Process for the manufacture of highly concentrated solutions of fat soluble hormones and derivatives thereof | |
GB850923A (en) | Improvements in or relating to nail varnish removers | |
ES194153A1 (en) | A PROCEDURE FOR OBTAINING CELLULOSE ESTERS | |
GB619065A (en) | Improvements in or relating to a method of stabilising an aqueous solution of ascorbic acid (vitamin c) | |
GB1077039A (en) | A choline derivative and therapeutic compositions containing it | |
CA596932A (en) | Carboxylic acid and ester derivatives of 8-alkylnortropanes and methods for their preparation | |
GB931420A (en) | Injectable pharmaceutical compositions comprising 1-ethyl-1-methylpropyl carbamate | |
GB942876A (en) | Improvements in or relating to piperidylidene-thiaxanthene | |
GB712505A (en) | Improvements in and relating to therapeutic aqueous colloidal preparations containing calcium | |
IT1031094B (en) | STABLE COMPOSITION AND PROCEDURES TO INHIBIT THE POLYM ERIZATION OF UNSATURATED CARBOXYLIC ACID ESTERS | |
ES203915A2 (en) | A procedure for the obtaining of highly concentrated injectable preparations of steroid hormones (Machine-translation by Google Translate, not legally binding) | |
ES2075240T3 (en) | PROCEDURE TO FORM A STABLE COLLOID DISPERSION. | |
GB642971A (en) | Improvements in therapeutic preparations | |
JPS55164621A (en) | Stable solubilized liquid of vitamin k |